STAAR Surgical authorizes $50 million share repurchase program
STAA•STAAR Surgical authorized a share repurchase program of up to $50 million, expected to run for 12 months. The company reported $181.5 million in cash and investments and no debt as of July 3, 2026.
1. Repurchase details
STAAR Surgical’s board authorized the program at a regularly scheduled meeting. Repurchases may be made through open-market or private transactions, structured agreements, block trades or Rule 10b5-1 plans; management will determine timing, price and volume, and may modify, suspend or end the program. The company plans to use free cash flow and cash on hand. It reported about 50.1 million shares outstanding as of Aug. 7, 2026.
